title: Management of patients with atrial fibrillation: different therapeutic options and role of electrophysiology-guided approaches.
abstract: At present the approach to atrial fibrillation treatment is based on the electrophysiological patterns of atrial fibrillation (on the basis of multiple intra-atrial recordings or sophisticated new mapping techniques) only in a restricted minority of patients, those who are candidate to ablation of the substrate and/or of the triggers. Atrial fibrillation has a broad spectrum of clinical presentations and a heterogeneous electrophysiological pattern. The treatment of this arrhythmia, both with drugs and non pharmacological treatments, has been based, classically, on empirical basis and on a clinically-guided staged-approach. The limitations of pharmacological treatment led in recent years to the development of a wide spectrum of non pharmacological treatments. This implies a change in the approach to atrial fibrillation and the need to identify potentially ideal candidates to complex and expensive treatments. In this view it is currently under investigation the possibility to identify potential responders to a definitive treatment or a combination of treatments (both pharmacological and non-pharmacological) on the basis of the electrophysiological pattern.
authors.affiliation: Istituto di Cardiologia, Policlinico S. Orsola, Università degli Studi, Bologna, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Boriani
authors.forename: M
authors.initials: M
authors.lastname: Biffi
authors.forename: C
authors.initials: C
authors.lastname: Camanini
authors.forename: I
authors.initials: I
authors.lastname: Corazza
authors.forename: P
authors.initials: P
authors.lastname: Bartolini
authors.forename: G
authors.initials: G
authors.lastname: Calcagnini
authors.forename: V
authors.initials: V
authors.lastname: Barbaro
authors.forename: R
authors.initials: R
authors.lastname: Zannoli
authors.forename: A
authors.initials: A
authors.lastname: Branzi
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000503:physiopathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D004554:Electric Countershock; D004594:Electrophysiology; D006801:Humans; D012008:Recurrence
chemical_list: D000889:Anti-Arrhythmia Agents